U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H28N4O7
Molecular Weight 436.4589
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FR-144633

SMILES

CC(C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)CCCOC1=CC=C(C=C1)C(N)=N)C(O)=O

InChI

InChIKey=JFCXCBBSUORTNS-YOEHRIQHSA-N
InChI=1S/C20H28N4O7/c1-11(2)17(20(29)30)24-19(28)14(10-16(26)27)23-15(25)4-3-9-31-13-7-5-12(6-8-13)18(21)22/h5-8,11,14,17H,3-4,9-10H2,1-2H3,(H3,21,22)(H,23,25)(H,24,28)(H,26,27)(H,29,30)/t14-,17-/m0/s1

HIDE SMILES / InChI

Molecular Formula C20H28N4O7
Molecular Weight 436.4589
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia.
2008
Invited commentary.
2005-07
Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model.
2005-07
Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass.
2004-08
The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
2004
Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.
2003-08
A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects.
2003-05-01
Substance Class Chemical
Created
by admin
on Wed Apr 02 11:18:35 GMT 2025
Edited
by admin
on Wed Apr 02 11:18:35 GMT 2025
Record UNII
9SP2H336UF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FK-633
Preferred Name English
FR-144633
Code English
FR144633
Code English
N-(4-(4-(AMINOIMINOMETHYL)PHENOXY)-1-OXOBUTYL)-L-.ALPHA.-ASPARTYL-L-VALINE
Systematic Name English
FK633
Code English
L-VALINE, N-(N-(4-(4-(AMINOIMINOMETHYL)PHENOXY)-1-OXOBUTYL)-L-.ALPHA.-ASPARTYL)-
Systematic Name English
(2S)-2-((2S)-2-(4-(4-CARBAMIMIDOYLPHENOXY)BUTANAMIDO)-3-CARBOXYPROPANAMIDO)-3-METHYLBUTANOIC ACID
Systematic Name English
Code System Code Type Description
MANUFACTURER PRODUCT INFORMATION
FK-633
Created by admin on Wed Apr 02 11:18:35 GMT 2025 , Edited by admin on Wed Apr 02 11:18:35 GMT 2025
PRIMARY
CAS
147865-49-4
Created by admin on Wed Apr 02 11:18:35 GMT 2025 , Edited by admin on Wed Apr 02 11:18:35 GMT 2025
PRIMARY
EPA CompTox
DTXSID00163821
Created by admin on Wed Apr 02 11:18:35 GMT 2025 , Edited by admin on Wed Apr 02 11:18:35 GMT 2025
PRIMARY
PUBCHEM
132814
Created by admin on Wed Apr 02 11:18:35 GMT 2025 , Edited by admin on Wed Apr 02 11:18:35 GMT 2025
PRIMARY
FDA UNII
9SP2H336UF
Created by admin on Wed Apr 02 11:18:35 GMT 2025 , Edited by admin on Wed Apr 02 11:18:35 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY